|
HDAC2 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.7945000041486E-08 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.966259999997E-05 |
| Normal-vs-Stage2 |
1.435300E-04 |
| Normal-vs-Stage3 |
4.16879974984852E-10 |
| Normal-vs-Stage4 |
1.1975000000497E-06 |
| Stage1-vs-Stage2 |
2.376600E-01 |
| Stage1-vs-Stage3 |
1.736360E-03 |
| Stage1-vs-Stage4 |
4.304200E-02 |
| Stage2-vs-Stage3 |
3.766800E-01 |
| Stage2-vs-Stage4 |
6.723200E-01 |
| Stage3-vs-Stage4 |
5.994600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.97330000117901E-08 |
| Normal-vs-AfricanAmerican |
3.410500E-04 |
| Normal-vs-Asian |
8.504000E-02 |
| Caucasian-vs-AfricanAmerican |
8.697400E-01 |
| Caucasian-vs-Asian |
8.541000E-01 |
| AfricanAmerican-vs-Asian |
9.180600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.20240004011885E-09 |
| Normal-vs-Female |
5.56569999999867E-05 |
| Male-vs-Female |
2.726100E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.223680E-02 |
| Normal-vs-Age(41-60Yrs) |
1.78920000004634E-06 |
| Normal-vs-Age(61-80Yrs) |
1.92989999536763E-08 |
| Normal-vs-Age(81-100Yrs) |
1.84789999999602E-05 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.129200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.370600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.984100E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.816200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.174000E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.804400E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
4.955200E-01 |
| Normal-vs-Grade 2 |
4.625800E-04 |
| Normal-vs-Grade 3 |
2.62130317452147E-11 |
| Normal-vs-Grade 4 |
4.06610000114327E-08 |
| Grade 1-vs-Grade 2 |
2.900600E-01 |
| Grade 1-vs-Grade 3 |
6.241100E-03 |
| Grade 1-vs-Grade 4 |
1.140420E-02 |
| Grade 2-vs-Grade 3 |
1.96458999999205E-05 |
| Grade 2-vs-Grade 4 |
3.397600E-04 |
| Grade 3-vs-Grade 4 |
4.743400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
5.027300E-04 |
| Normal-vs-ccB subtype |
5.64199997832304E-09 |
| ccA subtype-vs-ccB subtype |
8.17010000000451E-05 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.39569999949119E-07 |
| Normal-vs-N1 |
2.837000E-04 |
| N0-vs-N1 |
1.210830E-01 |
|
|
